Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis (2018)
- Authors:
- USP affiliated authors: BITTENCOURT, MÁRCIO SOMMER - HU ; SANTOS FILHO, RAUL DIAS DOS - FM
- Unidades: HU; FM
- DOI: 10.20945/2359-3997000000023
- Subjects: DOENÇAS CARDIOVASCULARES; JEJUM
- Keywords: TRIGLYCERIDES; CARDIOVASCULAR RISK; METABOLIC SYNDROME
- Language: Inglês
- Imprenta:
- Source:
- Título: Archives of Endocrinology and Metabolism
- ISSN: 2359-3997
- Volume/Número/Paginação/Ano: v. 62, n. 2, p. 187-192, apr. 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
JANOVSKY, Carolina Castro Porto Silva et al. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis. Archives of Endocrinology and Metabolism, v. 62, n. 2, p. 187-192, 2018Tradução . . Disponível em: https://doi.org/10.20945/2359-3997000000023. Acesso em: 05 out. 2024. -
APA
Janovsky, C. C. P. S., Laurinavicius, A., Casena, F., Valente, V., Ferreira, C. E., Mangueira, C., et al. (2018). Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis. Archives of Endocrinology and Metabolism, 62( 2), 187-192. doi:10.20945/2359-3997000000023 -
NLM
Janovsky CCPS, Laurinavicius A, Casena F, Valente V, Ferreira CE, Mangueira C, Conceição R, Santos RD, Bittencourt MS. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis [Internet]. Archives of Endocrinology and Metabolism. 2018 ; 62( 2): 187-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.20945/2359-3997000000023 -
Vancouver
Janovsky CCPS, Laurinavicius A, Casena F, Valente V, Ferreira CE, Mangueira C, Conceição R, Santos RD, Bittencourt MS. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis [Internet]. Archives of Endocrinology and Metabolism. 2018 ; 62( 2): 187-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.20945/2359-3997000000023 - Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria
- The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk
- The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension
- Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study
- Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population
- Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines
- Association between clinical factors and self-underestimation of cardiovascular risk in subjects submitted to a routine health evaluation
- The obesity paradox on the treadmill: relationship between body mass index and positive exercise stress tests
- Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management
- Does physical activity influence the association between depressive symptoms and low-grade inflammation in adults?: a study of 8,048 adults
Informações sobre o DOI: 10.20945/2359-3997000000023 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas